Patients with ACS receiving drug-eluting stent (DES) or bare-metal stent (BMS) were analyzed in this retrospective cohort study in Veterans Health Administration hospitals from 2003 to 2004. American Heart Journal
Review the role of the endocannabinoid system in obesity and design weight reduction strategies for patients with obesity to reduce cardiovascular risk.
- Daiichi Sankyo and Eli Lilly have submitted a new-drug application for the antiplatelet drug prasugrel to the US FDA for the treatment of ACS patients who are managed with PCI. If approved for marketing, the brand name will be Effient. Heartwire
The American Association of Clinical Endocrinologists has released a statement on hormone replacement therapy and cardiovascular risk, emphasizing that HRT does not appear harmful in younger women in early menopause and may indeed be beneficial in this group. Heartwire
Medscape interviews Wadi N. Suki, MD, from The Kidney Institute and Baylor College of Medicine on the recent Dialysis Clinical Outcomes Revisited (DCOR) study. Medscape Nephrology
Vitamin D deficiency seems to be a risk factor of developing cardiovascular disease, a new study suggests, which may have broad public health implications. Medscape Medical News
Those who experienced an acute-stress response following the 9/11 terrorist attacks are at increased risk of cardiovascular ailments, despite the fact that most of them were not directly affected by this trauma, a new study shows. The risk appears particularly high in those who had acute stress and have also been plagued by ongoing concerns about terrorism. Heartwire
Statins reduced all-cause mortality in elderly patients with documented coronary heart disease, and the magnitude of this effect was substantially larger than had been previously estimated. Medscape Medical News
Phobia, obsessive thinking, social shyness, and other anxiety characteristics are independent predictors of subsequent myocardial infarction at an average of 12 years in older men, a study shows. Medscape Medical News
